君实生物 (688180)

Shanghai Junshi Biosciences Co., Ltd.

KSH

Tags

Shanghai Free Trade ZoneInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareContains H-SharesBiological ProductsBiological VaccinesBelow IPO PriceSTAR Market 50 IndexSTAR Market Biotechnology IndexTechnology Growth LayerMargin Trading and Securities LendingNon-Cyclical Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

暂无最新财报数据。

2. Main Business

The main business covers:

  • Discovery of innovative drugs
  • Clinical research and development worldwide
  • From large-scale production to commercialization

3. Company Basic Information

  • Company Name: Shanghai Junshi Biosciences Co., Ltd.
  • Listing Date: 2020-07-15
  • Industry: Pharmaceutical Manufacturing
  • Address: Floor 16, Building 7, No. 100, Lane 6, Pingjiaqiao Road, Pudong New Area, Shanghai
  • Website: https://www.junshipharma.com/
  • Company Profile: On February 16, 2015, Huapu Tianjian issued the Audit Report No. HZTJ[2015]0773 for Shanghai Junshi Biosciences Co., Ltd. According to this audit report, as of December 31, 2014, the net assets of Junshi Limited were RMB 124,309,420.08. On February 16, 2015, Zhongshui Zhiyuan Asset Appraisal Co., Ltd. issued the Asset Appraisal Report No. ZSZY[2015]2108 for the project of Shanghai Junshi Biosciences Co., Ltd. intending to change its overall structure to establish a joint stock limited company. According to this appraisal report, as of the appraisal base date of December 31, 2014, the book value of Junshi Limited's net assets was RMB 124.3094 million, and the appraisal result of net assets was RMB 124.4209 million. On March 5, 2015, Junshi Limited held a shareholders' meeting and passed a resolution agreeing to change Junshi Limited into a joint stock limited company with all shareholders of Junshi Limited as the promoters; all promoters subscribed for shares by converting the audited net assets of Junshi Limited, RMB 124,309,420.08, into 14.7 million shares at a ratio of 1:0.11825, with the original shareholders of Junshi Limited subscribing for shares based on their respective shareholding ratios in Junshi Limited corresponding to the net assets. On March 27, 2015, all shareholders of Junshi Limited signed the "Sponsor Agreement for Shanghai Junshi Biosciences Co., Ltd.", unanimously agreeing to change Junshi Limited into a joint stock limited company. On March 27, 2015, Huapu Tianjian issued the Capital Verification Report No. HZTJ[2015]2013, verifying that as of March 27, 2015, the company (preparatory) had received the registered capital of RMB 14.7 million paid by all promoters. On March 27, 2015, the company held its founding meeting and the first shareholders' meeting in 2015, reviewing and passing the "Proposal on the Overall Change and Establishment of Shanghai Junshi Biosciences Co., Ltd." and other relevant proposals related to the change to a joint stock limited company, agreeing to change Junshi Limited into a joint stock limited company. In April 2015, all promoters of the company jointly signed the "Articles of Association of Shanghai Junshi Biosciences Co., Ltd.". On April 15, 2015, the Shanghai Administration for Industry and Commerce issued the "Pre-approval Notice for Enterprise Name Change" (No. 01201504150052) to the company, pre-approving the name change of Junshi Limited to "Shanghai Junshi Biosciences Co., Ltd.". On May 5, 2015, the Shanghai Administration for Industry and Commerce issued the "Business License" (Unified Social Credit Code: 91310000059383413A) to the company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
No data available

5. Concept Sectors

  • No relevant concept sectors available

Remarks

  • Data update date: Not specified in the provided information
  • Data source: Public market information